221 related articles for article (PubMed ID: 27345588)
41. Associations among treatment-related neurological risk factors and neuropsychological functioning in survivors of childhood brain tumor.
McCurdy MD; Rane S; Daly BP; Jacobson LA
J Neurooncol; 2016 Mar; 127(1):137-44. PubMed ID: 26725098
[TBL] [Abstract][Full Text] [Related]
42. High occurrence of sleep problems in survivors of a childhood brain tumor with neurocognitive complaints: The association with psychosocial and behavioral executive functioning.
van Kooten JAMC; Maurice-Stam H; Schouten AYN; van Vuurden DG; Granzen B; Gidding C; de Ruiter MA; van Litsenburg RRL; Grootenhuis MA
Pediatr Blood Cancer; 2019 Nov; 66(11):e27947. PubMed ID: 31418996
[TBL] [Abstract][Full Text] [Related]
43. Chemotherapy and attentional dysfunction in survivors of childhood acute lymphoblastic leukemia: effect of treatment intensity.
Buizer AI; de Sonneville LM; van den Heuvel-Eibrink MM; Veerman AJ
Pediatr Blood Cancer; 2005 Sep; 45(3):281-90. PubMed ID: 15806539
[TBL] [Abstract][Full Text] [Related]
44. Dexamethasone exposure and memory function in adult survivors of childhood acute lymphoblastic leukemia: A report from the SJLIFE cohort.
Edelmann MN; Ogg RJ; Scoggins MA; Brinkman TM; Sabin ND; Pui CH; Srivastava DK; Robison LL; Hudson MM; Krull KR
Pediatr Blood Cancer; 2013 Nov; 60(11):1778-84. PubMed ID: 23775832
[TBL] [Abstract][Full Text] [Related]
45. Sex-Specific Associations Between Chemotherapy, Chronic Conditions, and Neurocognitive Impairment in Acute Lymphoblastic Leukemia Survivors: A Report From the Childhood Cancer Survivor Study.
van der Plas E; Qiu W; Nieman BJ; Yasui Y; Liu Q; Dixon SB; Kadan-Lottick NS; Weldon CB; Weil BR; Jacola LM; Gibson TM; Leisenring W; Oeffinger K; Hudson MM; Robison LL; Armstrong GT; Krull KR
J Natl Cancer Inst; 2021 May; 113(5):588-596. PubMed ID: 32882041
[TBL] [Abstract][Full Text] [Related]
46. Neurocognitive and Patient-Reported Outcomes in Adult Survivors of Childhood Osteosarcoma.
Edelmann MN; Daryani VM; Bishop MW; Liu W; Brinkman TM; Stewart CF; Mulrooney DA; Kimberg C; Ness KK; Cheung YT; Srivastava DK; Robison LL; Hudson MM; Krull KR
JAMA Oncol; 2016 Feb; 2(2):201-8. PubMed ID: 26583357
[TBL] [Abstract][Full Text] [Related]
47. Genetic mediators of neurocognitive outcomes in survivors of childhood acute lymphoblastic leukemia.
Krull KR; Bhojwani D; Conklin HM; Pei D; Cheng C; Reddick WE; Sandlund JT; Pui CH
J Clin Oncol; 2013 Jun; 31(17):2182-8. PubMed ID: 23650422
[TBL] [Abstract][Full Text] [Related]
48. Serum uric acid and subsequent cognitive performance in patients with pre-existing cardiovascular disease.
Molshatzki N; Weinstein G; Streifler JY; Goldbourt U; Tanne D
PLoS One; 2015; 10(3):e0120862. PubMed ID: 25794156
[TBL] [Abstract][Full Text] [Related]
49. Neurocognitive outcomes among children who experienced seizures during treatment for acute lymphoblastic leukemia.
Nassar SL; Conklin HM; Zhou Y; Ashford JM; Reddick WE; Glass JO; Laningham FH; Jeha S; Cheng C; Pui CH
Pediatr Blood Cancer; 2017 Aug; 64(8):. PubMed ID: 28130818
[TBL] [Abstract][Full Text] [Related]
50. Folate pathway polymorphisms predict deficits in attention and processing speed after childhood leukemia therapy.
Kamdar KY; Krull KR; El-Zein RA; Brouwers P; Potter BS; Harris LL; Holm S; Dreyer Z; Scaglia F; Etzel CJ; Bondy M; Okcu MF
Pediatr Blood Cancer; 2011 Sep; 57(3):454-60. PubMed ID: 21618410
[TBL] [Abstract][Full Text] [Related]
51. Association between fatigue and sleep disturbances during treatment for pediatric acute lymphoblastic leukemia and posttreatment neurocognitive performance.
Vasquez P; Escalante J; Raghubar KP; Kahalley LS; Taylor OA; Moore IK; Hockenberry MJ; Scheurer ME; Brown AL
Pediatr Blood Cancer; 2022 May; 69(5):e29507. PubMed ID: 34889514
[TBL] [Abstract][Full Text] [Related]
52. Long-term neurocognitive outcomes in young adult survivors of childhood acute lymphoblastic leukemia.
Edelstein K; D'agostino N; Bernstein LJ; Nathan PC; Greenberg ML; Hodgson DC; Millar BA; Laperriere N; Spiegler BJ
J Pediatr Hematol Oncol; 2011 Aug; 33(6):450-8. PubMed ID: 21646917
[TBL] [Abstract][Full Text] [Related]
53. The changing burden of long-term health outcomes in survivors of childhood acute lymphoblastic leukaemia: a retrospective analysis of the St Jude Lifetime Cohort Study.
Mulrooney DA; Hyun G; Ness KK; Bhakta N; Pui CH; Ehrhardt MJ; Krull KR; Crom DB; Chemaitilly W; Srivastava DK; Relling MV; Jeha S; Green DM; Yasui Y; Robison LL; Hudson MM
Lancet Haematol; 2019 Jun; 6(6):e306-e316. PubMed ID: 31078468
[TBL] [Abstract][Full Text] [Related]
54. Association of Bacteremic Sepsis With Long-term Neurocognitive Dysfunction in Pediatric Patients With Acute Lymphoblastic Leukemia.
Cheung YT; Eskind A; Inaba H; Hudson MM; Pui CH; Krull KR; Wolf J
JAMA Pediatr; 2018 Nov; 172(11):1092-1095. PubMed ID: 30264151
[TBL] [Abstract][Full Text] [Related]
55. Rationale and design of a cohort study on primary ovarian insufficiency in female survivors of Hodgkin's lymphoma: influence on long-term adverse effects (SOPHIA).
Krul IM; Opstal-van Winden AWJ; Zijlstra JM; Appelman Y; Schagen SB; Meijboom LJ; Serné E; Lambalk CB; Lips P; van Dulmen-den Broeder E; Hauptmann M; Daniëls LA; Aleman BMP; van Leeuwen FE
BMJ Open; 2018 Sep; 8(9):e018120. PubMed ID: 30206072
[TBL] [Abstract][Full Text] [Related]
56. The relationship between serum uric acid and cognitive function in patients with chronic heart failure.
Niu W; Yang H; Lu C
BMC Cardiovasc Disord; 2020 Aug; 20(1):381. PubMed ID: 32819289
[TBL] [Abstract][Full Text] [Related]
57. Neurocognitive and Behavioral Outcomes of Chinese Survivors of Childhood Lymphoblastic Leukemia.
Peng L; Yang LS; Yam P; Lam CS; Chan AS; Li CK; Cheung YT
Front Oncol; 2021; 11():655669. PubMed ID: 33959507
[TBL] [Abstract][Full Text] [Related]
58. Late-onset Cognitive Impairment and Modifiable Risk Factors in Adult Childhood Cancer Survivors.
Phillips NS; Stratton KL; Williams AM; Ahles T; Ness KK; Cohen HJ; Edelstein K; Yasui Y; Oeffinger K; Chow EJ; Howell RM; Robison LL; Armstrong GT; Leisenring WM; Krull KR
JAMA Netw Open; 2023 May; 6(5):e2316077. PubMed ID: 37256617
[TBL] [Abstract][Full Text] [Related]
59. Neurocognitive, psychosocial, and quality-of-life outcomes in adult survivors of childhood non-Hodgkin lymphoma.
Ehrhardt MJ; Mulrooney DA; Li C; Baassiri MJ; Bjornard K; Sandlund JT; Brinkman TM; Huang IC; Srivastava DK; Ness KK; Robison LL; Hudson MM; Krull KR
Cancer; 2018 Jan; 124(2):417-425. PubMed ID: 28915338
[TBL] [Abstract][Full Text] [Related]
60. Serum uric acid is associated with metabolic risk factors for cardiovascular disease in the Uygur population.
Li NF; Wang HM; Yang J; Zhou L; Yao XG; Hong J
Appl Physiol Nutr Metab; 2009 Dec; 34(6):1032-9. PubMed ID: 20029511
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]